Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1291, 2010-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New warnings of renal dysfunction associated with Aclasta
Reactions Weekly, Vol. 1, Iss. 1324, 2010-01 ,pp. :
Access to resources
Recommend
Gemifloxacin offers advantages over clarithromycin for AECB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 331, 2001-01 ,pp. :
Buprenorphine offers no significant advantage over methadone
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. :
Gemifloxacin offers advantages over clarithromycin for AECB
Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. :
Buprenorphine offers no significant advantage over methadone
Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. :